Dizhe Pharmaceutical (688192.SH) issued an announcement. As of February 18, 2024, the company's chairman and chief...
Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) announced that as of February 18, 2024, Dr. Zhang Xiaolin, the chairman and CEO of the company, had increased his holdings of the company's shares by 161,000 shares through centralized bidding through the Shanghai Stock Exchange system, accounting for 0.0387% of the company's total share capital. The increase amount of shares was 50802.43 million yuan, which has exceeded the lower limit of the amount of shares to be increased in its current holdings increase plan.